Skip to main content
Figure 3 | BMC Medical Genomics

Figure 3

From: Imaging genomic mapping of an invasive MRI phenotype predicts patient outcome and metabolic dysfunction: a TCGA glioma phenotype research group project

Figure 3

Kaplan Meier survival curve: enhancing tumor across midline/corpus callosum. Kaplan Meier method was used to compute overall median survival. Those who had enhancement across the midline versus those patients with absence of enhancement across the midline demonstrated a median overall survival of 9 months versus 14.3 months (p < 0.0003).

Back to article page
\